(GERN:Consolidated Issue Listed on NASDAQ Global Select )
Earnings & Estimates Summary - GERON CORP (GERN)
2013 revenues at Geron Corporation totaled $1.3M USD, while annual losses equaled $0.29 per share.
Quarterly Earnings & Estimates - GERON CORP (GERN)
Geron Corporation's Quarterly Earnings
Geron Corporation reported 1st quarter 2014 losses of $0.06 per share on 05/3/2014.
Annual Earnings & Estimates - GERON CORP (GERN)
Geron Corporation's Annual Earnings
Geron Corporation reported annual 2013 losses of $0.29 per share on 03/19/2014.
Quarterly Revenues - GERON CORP (GERN)
Geron Corporation's Quarterly Revenues
Geron Corporation had 1st quarter 2014 revenues of $474.0K USD. This missed the $571.8K USD consensus estimate of the 4 analysts following the company. This was -38.0% below the prior year's 1st quarter results.
Annual Revenues - GERON CORP (GERN)
Geron Corporation's Annual Revenues
Geron Corporation had revenues for the full year 2013 of $1.3M USD. This was -52.6% below the prior year's results.
|BioTime Inc||$3.08 USD||+0.13|
|Neuralstem Inc||$1.51 USD||+0.03|
|Ocata Therapeutics Inc||$3.84 USD||+0.07|
|ReNeuron Group PLC||5.38 GBp||0.00|
|StemCells Inc||$0.40 USD||+0.012|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|